1. Home
  2. VET vs GENB Comparison

VET vs GENB Comparison

Compare VET & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vermilion Energy Inc.

VET

Vermilion Energy Inc.

HOLD

Current Price

$12.44

Market Cap

2.0B

Sector

Energy

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$11.46

Market Cap

1.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VET
GENB
Founded
1994
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
VET
GENB
Price
$12.44
$11.46
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$15.00
$25.00
AVG Volume (30 Days)
3.1M
364.6K
Earning Date
05-06-2026
05-03-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.01
N/A
Revenue Next Year
$3.02
$45.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$11.00
52 Week High
$14.82
$14.21

Technical Indicators

Market Signals
Indicator
VET
GENB
Relative Strength Index (RSI) 48.22 44.08
Support Level $7.42 $11.21
Resistance Level $14.55 $13.69
Average True Range (ATR) 0.61 1.12
MACD -0.21 -0.10
Stochastic Oscillator 7.11 9.65

Price Performance

Historical Comparison
VET
GENB

About VET Vermilion Energy Inc.

Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, and development of liquids-rich natural gas in Canada and conventional natural gas in Europe while optimizing low-decline oil assets. Its operating segments are: Canada, France, Netherlands, Germany, Ireland, Australia, and CEE, each representing the oil and gas exploration operations at its assets located in these regions. The company mainly derives revenue from the production and sale of petroleum and natural gas. The majority of its revenue is generated from Canada, where the company's operations are mainly focused on the Deep Basin trend in the West Pembina region of Alberta and on the Mica property.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: